Bangkok Dusit Medical Services Public Company Limited (BDMS)

Name: Bangkok Dusit Medical Services Public Company Limited (BDMS) — histórico de demonstrações financeiras
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

Histórico de receita, lucros e fluxo de caixa das demonstrações financeiras oficiais.

Healthcare · Wall Street (EUA) · Última atualização: 2026-09-19

Bangkok Dusit Medical Services Public Company Limited, together with its subsidiaries, operates hospitals in Thailand and internationally. It operates through two segments Hospital Operations; and Other Businesses That Support Hospital Business. The company operates hospitals under the Bangkok Hospital Group, Samitivej Hospital Group, BNH Hospital, Phyathai Hospital Group, Paolo Hospital, and Royal Hospital Group names; and BDMS Wellness Clinic.

Números-chave

Capitalização de mercado: THB 316 billion
Receita (exercício encerrado em 2025-12-31): THB 111.5B
Lucro líquido: THB 15.8B
Margem bruta: 36.1%
Margem líquida: 14.2%

Ver gráficos interativos e demonstrações completas →

Demonstração de resultados anual

Demonstração de resultados	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Receita total	THB 111.5B	THB 107.9B	THB 100.9B	THB 91.9B	—
Lucro bruto	THB 40.2B	THB 39.8B	THB 37.4B	THB 33.6B	—
Resultado Operacional (EBIT)	THB 20.2B	THB 20.5B	THB 18.9B	THB 17.0B	—
Resultado líquido	THB 15.8B	THB 16.0B	THB 14.4B	THB 12.6B	—

Fonte: relatórios públicos da empresa (SEC). Verifique no SEC EDGAR antes de confiar em qualquer número.

Balanços, fluxos de caixa, dados trimestrais e indicadores completos no visualizador interativo de BDMS. /companies/us/BDMS

Empresas semelhantes

As informações deste site são apenas educacionais e informativas; não constituem recomendação de investimento. Não publicamos preços-alvo nem recomendações.

English version →Todas as ações

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.